 | • レポートコード：QYR9ST04436 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、皮膚壊死治療の世界市場について調査・分析し、皮膚壊死治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（免疫抑制剤、コルチコステロイド）、用途別（病院、診療所、外来手術センター）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の皮膚壊死治療市場動向 ・主要企業別マーケットシェア ・皮膚壊死治療の種類別市場規模2014-2019 （免疫抑制剤、コルチコステロイド） ・皮膚壊死治療の用途別市場規模2014-2019 （病院、診療所、外来手術センター） ・皮膚壊死治療の北米市場：主要企業・種類別/用途別市場規模 ・皮膚壊死治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・皮膚壊死治療の中国市場：主要企業・種類別/用途別市場規模 ・皮膚壊死治療の日本国内市場：主要企業・種類別/用途別市場規模 ・皮膚壊死治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・皮膚壊死治療のインド市場：主要企業・種類別/用途別市場規模 ・皮膚壊死治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Baxter、Boston Therapeutics、Amgen、AstraZeneca、Glaxo Smithkline Pharmaceuticals、Systopic Laboratories、Sun Pharmaceuticals、RPG Life Sciences、Zydus Cadila） ・皮膚壊死治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Acute cutaneous necrosis can be defined as a skin disease with sudden onset of tissue death that results in significant morbidity and is usually, but not always, excruciatingly painful. Early diagnosis can allow for early therapy and can decrease the chances of morbidity and loss of life. A thorough history is mandatory including recent reavel, drugs, underlying illnesses and recent surgical procedures. Blood tests that are often helpful are creatinine phosphokinase, blood cultures, antinuclear antibodies, rheumatoid factor, antinuclear cytoplasmic antibodies, hypercoagulability screen, creatinine, complete blood count and human immunodeficiency virus test. Other procedures such as computerized axial tomography and magnetic resonance imaging also helps to determine the extent of disease.The dermal necrosis market is expected to witness growth as it is a highly undiscovered area. Moreover, Coumadin necrosis, Heparin necrosis and Calciphylaxis are diseases for which no therapies are proven beneficial. This offers an area of unmet needs where market players can develop a molecule and form a strong position in the dermal necrosis treatment market. TISSEEL Kit, from Baxter is an example of device which is used for management of skin necrosis and mucosal ulcers. The device is a two-component fibrin sealant offers highly concentrated human fibrinogen to seal tissue and stop diffuse bleeding.
In 2018, the global Dermal Necrosis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Dermal Necrosis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Dermal Necrosis Treatment development in United States, Europe and China.
The key players covered in this study
Baxter
Boston Therapeutics
Amgen
AstraZeneca
Glaxo Smithkline Pharmaceuticals
Systopic Laboratories
Sun Pharmaceuticals
RPG Life Sciences
Zydus Cadila
Market segment by Type, the product can be split into
Immunosuppressive Agents
Corticosteroids
Market segment by Application, split into
Hospital
Clinics
Ambulatory Surgery Center
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Dermal Necrosis Treatment status, future forecast, growth opportunity, key market and key players.
To present the Dermal Necrosis Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Dermal Necrosis Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Dermal Necrosis Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Immunosuppressive Agents
1.4.3 Corticosteroids
1.5 Market by Application
1.5.1 Global Dermal Necrosis Treatment Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Clinics
1.5.4 Ambulatory Surgery Center
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Dermal Necrosis Treatment Market Size
2.2 Dermal Necrosis Treatment Growth Trends by Regions
2.2.1 Dermal Necrosis Treatment Market Size by Regions (2014-2025)
2.2.2 Dermal Necrosis Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Dermal Necrosis Treatment Market Size by Manufacturers
3.1.1 Global Dermal Necrosis Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Dermal Necrosis Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Dermal Necrosis Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Dermal Necrosis Treatment Key Players Head office and Area Served
3.3 Key Players Dermal Necrosis Treatment Product/Solution/Service
3.4 Date of Enter into Dermal Necrosis Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Dermal Necrosis Treatment Market Size by Type (2014-2019)
4.2 Global Dermal Necrosis Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Dermal Necrosis Treatment Market Size (2014-2019)
5.2 Dermal Necrosis Treatment Key Players in United States
5.3 United States Dermal Necrosis Treatment Market Size by Type
5.4 United States Dermal Necrosis Treatment Market Size by Application
6 Europe
6.1 Europe Dermal Necrosis Treatment Market Size (2014-2019)
6.2 Dermal Necrosis Treatment Key Players in Europe
6.3 Europe Dermal Necrosis Treatment Market Size by Type
6.4 Europe Dermal Necrosis Treatment Market Size by Application
7 China
7.1 China Dermal Necrosis Treatment Market Size (2014-2019)
7.2 Dermal Necrosis Treatment Key Players in China
7.3 China Dermal Necrosis Treatment Market Size by Type
7.4 China Dermal Necrosis Treatment Market Size by Application
8 Japan
8.1 Japan Dermal Necrosis Treatment Market Size (2014-2019)
8.2 Dermal Necrosis Treatment Key Players in Japan
8.3 Japan Dermal Necrosis Treatment Market Size by Type
8.4 Japan Dermal Necrosis Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Dermal Necrosis Treatment Market Size (2014-2019)
9.2 Dermal Necrosis Treatment Key Players in Southeast Asia
9.3 Southeast Asia Dermal Necrosis Treatment Market Size by Type
9.4 Southeast Asia Dermal Necrosis Treatment Market Size by Application
10 India
10.1 India Dermal Necrosis Treatment Market Size (2014-2019)
10.2 Dermal Necrosis Treatment Key Players in India
10.3 India Dermal Necrosis Treatment Market Size by Type
10.4 India Dermal Necrosis Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Dermal Necrosis Treatment Market Size (2014-2019)
11.2 Dermal Necrosis Treatment Key Players in Central & South America
11.3 Central & South America Dermal Necrosis Treatment Market Size by Type
11.4 Central & South America Dermal Necrosis Treatment Market Size by Application
12 International Players Profiles
12.1 Baxter
12.1.1 Baxter Company Details
12.1.2 Company Description and Business Overview
12.1.3 Dermal Necrosis Treatment Introduction
12.1.4 Baxter Revenue in Dermal Necrosis Treatment Business (2014-2019)
12.1.5 Baxter Recent Development
12.2 Boston Therapeutics
12.2.1 Boston Therapeutics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Dermal Necrosis Treatment Introduction
12.2.4 Boston Therapeutics Revenue in Dermal Necrosis Treatment Business (2014-2019)
12.2.5 Boston Therapeutics Recent Development
12.3 Amgen
12.3.1 Amgen Company Details
12.3.2 Company Description and Business Overview
12.3.3 Dermal Necrosis Treatment Introduction
12.3.4 Amgen Revenue in Dermal Necrosis Treatment Business (2014-2019)
12.3.5 Amgen Recent Development
12.4 AstraZeneca
12.4.1 AstraZeneca Company Details
12.4.2 Company Description and Business Overview
12.4.3 Dermal Necrosis Treatment Introduction
12.4.4 AstraZeneca Revenue in Dermal Necrosis Treatment Business (2014-2019)
12.4.5 AstraZeneca Recent Development
12.5 Glaxo Smithkline Pharmaceuticals
12.5.1 Glaxo Smithkline Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Dermal Necrosis Treatment Introduction
12.5.4 Glaxo Smithkline Pharmaceuticals Revenue in Dermal Necrosis Treatment Business (2014-2019)
12.5.5 Glaxo Smithkline Pharmaceuticals Recent Development
12.6 Systopic Laboratories
12.6.1 Systopic Laboratories Company Details
12.6.2 Company Description and Business Overview
12.6.3 Dermal Necrosis Treatment Introduction
12.6.4 Systopic Laboratories Revenue in Dermal Necrosis Treatment Business (2014-2019)
12.6.5 Systopic Laboratories Recent Development
12.7 Sun Pharmaceuticals
12.7.1 Sun Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Dermal Necrosis Treatment Introduction
12.7.4 Sun Pharmaceuticals Revenue in Dermal Necrosis Treatment Business (2014-2019)
12.7.5 Sun Pharmaceuticals Recent Development
12.8 RPG Life Sciences
12.8.1 RPG Life Sciences Company Details
12.8.2 Company Description and Business Overview
12.8.3 Dermal Necrosis Treatment Introduction
12.8.4 RPG Life Sciences Revenue in Dermal Necrosis Treatment Business (2014-2019)
12.8.5 RPG Life Sciences Recent Development
12.9 Zydus Cadila
12.9.1 Zydus Cadila Company Details
12.9.2 Company Description and Business Overview
12.9.3 Dermal Necrosis Treatment Introduction
12.9.4 Zydus Cadila Revenue in Dermal Necrosis Treatment Business (2014-2019)
12.9.5 Zydus Cadila Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Dermal Necrosis Treatment Key Market Segments
Table Key Players Dermal Necrosis Treatment Covered
Table Global Dermal Necrosis Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Dermal Necrosis Treatment Market Size Market Share by Type 2014-2025
Figure Immunosuppressive Agents Figures
Table Key Players of Immunosuppressive Agents
Figure Corticosteroids Figures
Table Key Players of Corticosteroids
Table Global Dermal Necrosis Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Case Studies
Figure Clinics Case Studies
Figure Ambulatory Surgery Center Case Studies
Figure Dermal Necrosis Treatment Report Years Considered
Table Global Dermal Necrosis Treatment Market Size 2014-2025 (Million US$)
Figure Global Dermal Necrosis Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Dermal Necrosis Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Dermal Necrosis Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Dermal Necrosis Treatment Market Share by Regions 2014-2019
Figure Global Dermal Necrosis Treatment Market Share by Regions 2014-2019
Figure Global Dermal Necrosis Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Dermal Necrosis Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Dermal Necrosis Treatment Market Share by Manufacturers (2014-2019)
Figure Global Dermal Necrosis Treatment Market Share by Manufacturers in 2018
Table Global Dermal Necrosis Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Dermal Necrosis Treatment Product/Solution/Service
Table Date of Enter into Dermal Necrosis Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Dermal Necrosis Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Dermal Necrosis Treatment Market Size Share by Type (2014-2019)
Figure Global Dermal Necrosis Treatment Market Size Market Share by Type (2014-2019)
Table Global Dermal Necrosis Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Dermal Necrosis Treatment Market Size Share by Application (2014-2019)
Figure Global Dermal Necrosis Treatment Market Size Market Share by Application (2014-2019)
Figure Global Dermal Necrosis Treatment Revenue Market Share by Application in 2018
Figure United States Dermal Necrosis Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Dermal Necrosis Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Dermal Necrosis Treatment Market Share (2018-2019)
Table United States Dermal Necrosis Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Dermal Necrosis Treatment Market Share by Type (2014-2019)
Table United States Dermal Necrosis Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Dermal Necrosis Treatment Market Share by Application (2014-2019)
Figure Europe Dermal Necrosis Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Dermal Necrosis Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Dermal Necrosis Treatment Market Share (2018-2019)
Table Europe Dermal Necrosis Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Dermal Necrosis Treatment Market Share by Type (2014-2019)
Table Europe Dermal Necrosis Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Dermal Necrosis Treatment Market Share by Application (2014-2019)
Figure China Dermal Necrosis Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Dermal Necrosis Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Dermal Necrosis Treatment Market Share (2018-2019)
Table China Dermal Necrosis Treatment Market Size by Type (2014-20189) (Million US$)
Table China Dermal Necrosis Treatment Market Share by Type (2014-2019)
Table China Dermal Necrosis Treatment Market Size by Application (2014-2019) (Million US$)
Table China Dermal Necrosis Treatment Market Share by Application (2014-2019)
Figure Japan Dermal Necrosis Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Dermal Necrosis Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Dermal Necrosis Treatment Market Share (2018-2019)
Table Japan Dermal Necrosis Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Dermal Necrosis Treatment Market Share by Type (2014-2019)
Table Japan Dermal Necrosis Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Dermal Necrosis Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Dermal Necrosis Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Dermal Necrosis Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Dermal Necrosis Treatment Market Share (2018-2019)
Table Southeast Asia Dermal Necrosis Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Dermal Necrosis Treatment Market Share by Type (2014-2019)
Table Southeast Asia Dermal Necrosis Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Dermal Necrosis Treatment Market Share by Application (2014-2019)
Figure India Dermal Necrosis Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Dermal Necrosis Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Dermal Necrosis Treatment Market Share (2018-2019)
Table India Dermal Necrosis Treatment Market Size by Type (2014-2019) (Million US$)
Table India Dermal Necrosis Treatment Market Share by Type (2014-2019)
Table India Dermal Necrosis Treatment Market Size by Application (2014-2019) (Million US$)
Table India Dermal Necrosis Treatment Market Share by Application (2014-2019)
Figure Central & South America Dermal Necrosis Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Dermal Necrosis Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Dermal Necrosis Treatment Market Share (2018-2019)
Table Central & South America Dermal Necrosis Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Dermal Necrosis Treatment Market Share by Type (2014-2019)
Table Central & South America Dermal Necrosis Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Dermal Necrosis Treatment Market Share by Application (2014-2019)
Table Baxter Company Details
Table Baxter Revenue in Dermal Necrosis Treatment Business (2014-2019) (Million US$)
Figure Baxter Revenue Growth Rate in Dermal Necrosis Treatment Business (2014-2019)
Table Baxter Recent Development
Table Boston Therapeutics Company Details
Table Boston Therapeutics Revenue in Dermal Necrosis Treatment Business (2014-2019)(Million US$)
Figure Boston Therapeutics Revenue Growth Rate in Dermal Necrosis Treatment Business (2014-2019)
Table Boston Therapeutics Recent Development
Table Amgen Company Details
Table Amgen Revenue in Dermal Necrosis Treatment Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Dermal Necrosis Treatment Business (2014-2019)
Table Amgen Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Dermal Necrosis Treatment Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Dermal Necrosis Treatment Business (2014-2019)
Table AstraZeneca Recent Development
Table Glaxo Smithkline Pharmaceuticals Company Details
Table Glaxo Smithkline Pharmaceuticals Revenue in Dermal Necrosis Treatment Business (2014-2019)(Million US$)
Figure Glaxo Smithkline Pharmaceuticals Revenue Growth Rate in Dermal Necrosis Treatment Business (2014-2019)
Table Glaxo Smithkline Pharmaceuticals Recent Development
Table Systopic Laboratories Company Details
Table Systopic Laboratories Revenue in Dermal Necrosis Treatment Business (2014-2019)(Million US$)
Figure Systopic Laboratories Revenue Growth Rate in Dermal Necrosis Treatment Business (2014-2019)
Table Systopic Laboratories Recent Development
Table Sun Pharmaceuticals Company Details
Table Sun Pharmaceuticals Revenue in Dermal Necrosis Treatment Business (2014-2019)(Million US$)
Figure Sun Pharmaceuticals Revenue Growth Rate in Dermal Necrosis Treatment Business (2014-2019)
Table Sun Pharmaceuticals Recent Development
Table RPG Life Sciences Company Details
Table RPG Life Sciences Revenue in Dermal Necrosis Treatment Business (2014-2019)(Million US$)
Figure RPG Life Sciences Revenue Growth Rate in Dermal Necrosis Treatment Business (2014-2019)
Table RPG Life Sciences Recent Development
Table Zydus Cadila Company Details
Table Zydus Cadila Revenue in Dermal Necrosis Treatment Business (2014-2019)(Million US$)
Figure Zydus Cadila Revenue Growth Rate in Dermal Necrosis Treatment Business (2014-2019)
Table Zydus Cadila Recent Development
Table Global Dermal Necrosis Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Dermal Necrosis Treatment Market Size Share by Regions (2019-2025)
Figure Global Dermal Necrosis Treatment Market Size Share by Regions in 2025
Figure United States Dermal Necrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Dermal Necrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Dermal Necrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Dermal Necrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Dermal Necrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Dermal Necrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Dermal Necrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Dermal Necrosis Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Dermal Necrosis Treatment Market Size by Product (2019-2025)
Figure Global Dermal Necrosis Treatment Market Size by Product in 2025
Table Global Dermal Necrosis Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Dermal Necrosis Treatment Market Size by Application (2019-2025)
Figure Global Dermal Necrosis Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の美容整形用皮膚フィラー市場：専門的調査 Dermal fillers are used in cosmetic surgery to improve the skin’s appearance and to fill defects in the skin from superficial wrinkles to deeper lines. The global Dermal Fillers for Cosmetic Surgery market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing…- 皮膚キュレットの世界市場：インサイト・予測 The curette has a firm place in the range of dermatological, diagnostic and therapeutic instruments. It is one of the most versatile instruments. For that reason, it is increasingly also used in other disciplines, such as plastic surgery and gynaecology.The global Dermal Curette market is valued at …
- 世界の皮膚フィラー市場：専門的調査 Dermal fillers help to diminish facial lines and restore volume and fullness in the face. Dermal fillers can be used to: plump thin lips, enhance shallow contours, soften facial creases and wrinkles and improve the appearance of recessed scars Dermal fillers can be very helpful in those with early s…
- 世界の皮膚フィラー市場：専門的調査 Dermal fillers help to diminish facial lines and restore volume and fullness in the face. Dermal fillers can be used to: plump thin lips, enhance shallow contours, soften facial creases and wrinkles and improve the appearance of recessed scars Dermal fillers can be very helpful in those with early s…
- 世界の非生分解性皮膚フィラー市場：専門的調査 Dermal fillers help to diminish facial lines and restore volume and fullness in the face. The global Non-biodegradable Dermal Fillers market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Non-bi…